EPS Diluted (Quarterly) Chart

View EPS Diluted (Quarterly) for CPMD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
Lexaria Bioscience Corp. -0.0593
InMed Pharmaceuticals, Inc. -0.7327
Target Group, Inc. (Canada) -0.0009
Tilray Brands, Inc. -0.2358
NervGen Pharma Corp. -0.251